Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jasmine Handford
Observed names:
Handford, Jasmine,
J Handford,
J. Handford
Institutions:
Guy's Hospital,
King's College London,
Guy's and St Thomas' NHS Foundation Trust
Observed institutions:
Guy's Hospital,
King's College London,
Guy's and St Thomas' NHS Foundation Trust,
Chelsea and Westminster Hospital,
Velindre Cancer Centre
ORCID:
0000-0002-5341-0949
Observed ORCID:
0000-0002-5341-0949
OpenAlex ID:
A5015859098
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
2022
·
David J Pinato
, Daniela Ferrante
, et al.
·
The Lancet Oncology
·
80
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict
2022
·
M. Van Hemelrijck
, L. Fox
, et al.
·
Journal of Cancer Policy
·
26
PDF
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
2023
·
Marco Tagliamento
, Alessandra Gennari
, et al.
·
Journal of Clinical Oncology
·
13
PDF
Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review
2022
·
Jasmine Handford
, Miaoqi Chen
, et al.
·
Cancers
·
13
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post–COVID-19 Global Context: A Modified Delphi Consensus Process
2023
·
Louis Fox
, Aida Santaolalla
, et al.
·
JCO Global Oncology
·
3
PDF
Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic
2022
·
Hajer Hadi
, Jasmine Handford
, et al.
·
Future Oncology
·
1
Real world outcomes for patients with high grade neuroendocrine neoplasms at Guy's Cancer Centre
2025
·
Jasmine Handford
, Yamin Shwe Yee Soe
, et al.
·
Endocrine Abstracts
WITHDRAWN: 1005eP Toxicity of tumour infiltrating lymphocyte (TIL) therapy in solid tumours: Experience from a UK trials unit
2025
·
C. Yong
, L. Gomm
, et al.
·
Annals of Oncology
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Guy’s Cancer Cohort: Guy’s Cancer Centre’s Real-World Evidence Programme 5 years later
2025
·
C.L. Moss
, B. Russell
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
The experience of surgical cancer patients during the COVID-19 pandemic at a large cancer centre in London
2024
·
Beth Russell
, Hajer Hadi
, et al.
·
Supportive Care in Cancer
PDF
Show more works
View as search
Works count:
21
Citation count:
1,837
H-index:
12
I10-index:
12
Year
Topic
Type